Literature DB >> 12916680

Poor glucose control in women with type 1 diabetes mellitus and 'safe' hemoglobin A1c values in the first trimester of pregnancy.

A Kerssen1, I M Evers, H W de Valk, G H A Visser.   

Abstract

OBJECTIVE: To observe glycemic excursions, measured continuously over 24 h, in relation to hemoglobin A1c values in the first trimester of pregnancy of women with type 1 diabetes mellitus.
METHODS: The MiniMed Continuous Glucose Monitoring System (CGMS) was used to obtain glucose values every 5 min during 24 h. Hemoglobin A1c was determined at the end of the continuous glucose recording and 6-12 weeks after the continuous glucose recording.
RESULTS: Continuous glucose recordings were obtained in 13 women between 7 and 15 weeks of gestation. Nine patients had hemoglobin A1c levels of < or = 7.0% (< 1% above the upper limit of normal range) while up to 41.3% of the readings had values of < 3.9 mmol/l (70 mg/dl) and up to 52.8% of the readings had values of > 7.8 mmol/l (140 mg/dl).
CONCLUSIONS: Hemoglobin A1c does not reflect the complexities of glycemic control in women with type 1 diabetes who are considered to have accomplished tight glycemic control in the first trimester of pregnancy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12916680     DOI: 10.1080/jmf.13.5.309.313

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  13 in total

1.  Peri-conception hyperglycaemia and nephropathy are associated with risk of congenital anomaly in women with pre-existing diabetes: a population-based cohort study.

Authors:  R Bell; S V Glinianaia; P W G Tennant; R W Bilous; J Rankin
Journal:  Diabetologia       Date:  2012-02-08       Impact factor: 10.122

2.  Managing preexisting diabetes for pregnancy: summary of evidence and consensus recommendations for care.

Authors:  John L Kitzmiller; Jennifer M Block; Florence M Brown; Patrick M Catalano; Deborah L Conway; Donald R Coustan; Erica P Gunderson; William H Herman; Lisa D Hoffman; Maribeth Inturrisi; Lois B Jovanovic; Siri I Kjos; Robert H Knopp; Martin N Montoro; Edward S Ogata; Pathmaja Paramsothy; Diane M Reader; Barak M Rosenn; Alyce M Thomas; M Sue Kirkman
Journal:  Diabetes Care       Date:  2008-05       Impact factor: 19.112

3.  Do HbA1c levels and the self-monitoring of blood glucose levels adequately reflect glycaemic control during pregnancy in women with type 1 diabetes mellitus?

Authors:  A Kerssen; H W de Valk; G H A Visser
Journal:  Diabetologia       Date:  2005-12-09       Impact factor: 10.122

Review 4.  Birth defects in pregestational diabetes: Defect range, glycemic threshold and pathogenesis.

Authors:  Rinat Gabbay-Benziv; E Albert Reece; Fang Wang; Peixin Yang
Journal:  World J Diabetes       Date:  2015-04-15

5.  HbA(1c) and birthweight in women with pre-conception type 1 and type 2 diabetes: a population-based cohort study.

Authors:  S V Glinianaia; P W G Tennant; R W Bilous; J Rankin; R Bell
Journal:  Diabetologia       Date:  2012-09-27       Impact factor: 10.122

Review 6.  CGM, Pregnancy, and Remote Monitoring.

Authors:  Sarit Polsky; Rachel Garcetti
Journal:  Diabetes Technol Ther       Date:  2017-06       Impact factor: 6.118

7.  Brief hyperglycaemia in the early pregnant rat increases fetal weight at term by stimulating placental growth and affecting placental nutrient transport.

Authors:  Anette Ericsson; Karin Säljö; Eleonor Sjöstrand; Nina Jansson; Puttur D Prasad; Theresa L Powell; Thomas Jansson
Journal:  J Physiol       Date:  2007-04-12       Impact factor: 5.182

8.  Sibling birthweight as a predictor of macrosomia in women with type 1 diabetes.

Authors:  A Kerssen; H W de Valk; G H A Visser
Journal:  Diabetologia       Date:  2005-07-14       Impact factor: 10.122

9.  Pregnancy outcome in type 2 diabetes mellitus: a retrospective analysis from the Netherlands.

Authors:  Harold W de Valk; Nancy H G van Nieuwaal; Gerard H A Visser
Journal:  Rev Diabet Stud       Date:  2006-11-10

10.  Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands.

Authors:  Inge M Evers; Harold W de Valk; Gerard H A Visser
Journal:  BMJ       Date:  2004-04-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.